Crossmark

Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan

Crossref DOI link: https://doi.org/10.1186/s13063-021-05961-8

Published Online: 2022-01-20

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Yu

Huang, Yi-Shan https://orcid.org/0000-0003-0115-7694
Yang, Ze

Wang, Xinmiao

Li, Yanbo

Zhang, Ying

Zhao, Lin-Hua

Tong, Xiaolin
Funding

Funding for this research was provided by:

fundamental research funds for central universities of the central south university (No. ZZ0808004)

guang’s anmen hospital of the china academy of chinese medical science (No. 2015 s325)
License Information

Text and Data Mining valid from 2022-01-20

Version of Record valid from 2022-01-20
More Information

Article History

Received: 22 July 2021

Accepted: 21 December 2021

First Online: 20 January 2022

Declarations

:

: The trial was approved by the Ethics Committee of Guang’anmen Hospital prior to patient recruitment.

: The manuscript does not contain any individual person’s data in any form.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below